Clinical trial

Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

NCT03971929

Drugs and interventions used in this trial

3 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention SHR0532 Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention SHR placebo Find medicine records · Find other trials using this name

DRUG · Mapped RxNorm record Hydrochlorothiazide 25 mg Normalized identity: hydrochlorothiazide 25 MGView linked drug · Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Safety and Effect Study of SHR0532 (Drug Code) Tablets in Patients With Mild Hypertension

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2019-07-31

PhasePHASE1

Conditions

Hypertensionunresolved

Interventions

SHR0532DRUG

SHR placeboDRUG

Hydrochlorothiazide 25 mgDRUG · verified · RxNorm: hydrochlorothiazide 25 MG

Sponsors & collaborators

Jiangsu HengRui Medicine Co., Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03971929 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.